The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients
- PMID: 10651749
- DOI: 10.1046/j.1365-2265.2000.00862.x
The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients
Abstract
Objective: Hypopituitary adults on conventional replacement have low concentrations of metabolic fuels throughout the night, possibly related to GH deficiency or to decreased cortisol levels overnight. We investigated whether GH replacement corrects the overnight fuel deficiency.
Design: We measured circulating levels of metabolic fuels: glucose, non-esterified fatty acids (NEFA), glycerol and 3-hydroxybutyrate (3-OHB) and insulin concentrations over 24 h (from 0730 h to 0700 h) in hypopituitary adults before and after GH treatment in a randomized double-blind placebo-controlled trial of 3 months' duration.
Patients: Thirteen hypopituitary patients, 8 women and 5 men, were studied.
Results: Six patients (4 women and 2 men) received GH and 7 patients (4 women and 3 men) were allocated to receive placebo. There was no difference in fasting (0730 h), area under the curve (AUC) between 2400 h and 0700 h (overnight) and AUC over 24 h for plasma glucose, 3-OHB, glycerol and insulin concentrations as a result of GH treatment. Fasting and overnight AUC for NEFA were significantly higher on GH treatment ((mean +/- SEM) 243 +/- 29 vs. 446 +/- 90 micromol/l, P = 0.03, 1522 +/- 208 vs. 2167 +/- 123 micromol/l H, P = 0.046, respectively), but AUC over 24 h was not affected significantly. No significant changes in any fuel were seen in the placebo group. The changes in fasting, overnight and 24 h AUC for glucose, 3-OHB, glycerol and insulin levels with GH and with placebo for 3 months were similar. The changes in fasting and overnight AUC for NEFA before and after 3 months were significantly different in the group treated with GH vs. the group treated with placebo (median (lower-upper quartile) 104 (90-276) vs. -89 (-98 to 26) micromol/l, P = 0.002; 633 (263-967) vs. -895 (-1379 to -494) micromol/l h, P = 0.002, respectively), but the changes in 24-h AUC for NEFA were not significant between the two groups.
Conclusions: GH replacement in hypopituitary adults increases fasting and overnight (between 2400 h and 0700 h) non-esterified fatty acid concentrations, consistent with the known lipolytic effect of GH. GH did not influence the concentrations of other metabolic fuels or insulin.
Similar articles
-
Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.Clin Endocrinol (Oxf). 1996 Aug;45(2):171-8. doi: 10.1046/j.1365-2265.1996.d01-1552.x. Clin Endocrinol (Oxf). 1996. PMID: 8881449
-
Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.Clin Endocrinol (Oxf). 1995 Jan;42(1):85-90. doi: 10.1111/j.1365-2265.1995.tb02602.x. Clin Endocrinol (Oxf). 1995. PMID: 7889636
-
The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.J Clin Endocrinol Metab. 2001 Nov;86(11):5342-7. doi: 10.1210/jcem.86.11.8044. J Clin Endocrinol Metab. 2001. PMID: 11701703 Clinical Trial.
-
Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.Clin Endocrinol (Oxf). 1998 Jun;48(6):795-802. doi: 10.1046/j.1365-2265.1998.00460.x. Clin Endocrinol (Oxf). 1998. PMID: 9713570
-
Somatropin and glucose homeostasis: considerations for patient management.Treat Endocrinol. 2002;1(4):229-34. doi: 10.2165/00024677-200201040-00004. Treat Endocrinol. 2002. PMID: 15799216 Review.
Cited by
-
Long-term growth hormone replacement therapy in hypopituitary adults.Drugs. 2002;62(16):2399-412. doi: 10.2165/00003495-200262160-00006. Drugs. 2002. PMID: 12396230 Review.
-
Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients.Front Endocrinol (Lausanne). 2021 Feb 25;12:635983. doi: 10.3389/fendo.2021.635983. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716985 Free PMC article.
-
Circadian regulation of metabolic homeostasis: causes and consequences.Nat Sci Sleep. 2016 May 27;8:163-80. doi: 10.2147/NSS.S78946. eCollection 2016. Nat Sci Sleep. 2016. PMID: 27313482 Free PMC article. Review.
-
Increase in serum pregnancy-associated plasma protein-A is correlated with increase in cardiovascular risk factors in adult patients with growth hormone deficiency.Endocrine. 2012 Oct;42(2):375-81. doi: 10.1007/s12020-012-9697-9. Epub 2012 May 29. Endocrine. 2012. PMID: 22644835
-
Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.J Clin Endocrinol Metab. 2008 Jun;93(6):2109-14. doi: 10.1210/jc.2007-2266. Epub 2008 Mar 18. J Clin Endocrinol Metab. 2008. PMID: 18349057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical